Dr Agarwals Eye Hospital Ltd Shows Renewed Price Momentum Amid Bullish Technical Signals

Technical Momentum Gains Strength

The stock, currently trading at ₹5,460.00, has seen a day change of +2.49%, closing well above its previous close of ₹5,327.35. The intraday range was broad, with a low of ₹5,312.00 and a high touching ₹6,392.00, indicating heightened volatility and buying interest. Over the past week, Dr Agarwals Eye Hospital Ltd outperformed the Sensex with a 1.21% gain versus the benchmark’s 0.85%, although it lagged over the one-month horizon with a 4.07% decline compared to Sensex’s 0.73% rise.

Longer-term returns remain impressive, with a three-year cumulative return of 349.38% against Sensex’s 40.21%, and a remarkable five-year return of 1,922.22% compared to 79.16% for the benchmark. However, the stock has faced headwinds in the past year, declining 21.63% while the Sensex gained 7.28%, reflecting sector-specific challenges and broader market pressures.

MACD and Bollinger Bands Confirm Bullish Outlook

The Moving Average Convergence Divergence (MACD) indicator is signalling bullish momentum on both weekly and monthly charts, reinforcing the positive trend. The MACD line has crossed above the signal line, suggesting increasing upward momentum and potential for further price appreciation. Complementing this, Bollinger Bands on weekly and monthly timeframes are also bullish, with the price moving towards the upper band, indicating strong buying pressure and reduced volatility compression.

Despite these encouraging signs, the Relative Strength Index (RSI) remains neutral on both weekly and monthly scales, showing no overbought or oversold conditions. This suggests that the stock has room to run without immediate risk of a sharp correction, providing a favourable environment for sustained gains.

Moving Averages and KST Signal Positive Shift

Daily moving averages have turned bullish, with the stock price trading above its short-term and medium-term averages. This crossover is a classic technical signal that often precedes upward price movements. The Know Sure Thing (KST) indicator is bullish on the weekly chart, although mildly bearish on the monthly, indicating some caution over longer horizons but a positive near-term outlook.

Dow Theory assessments align with this view, showing mildly bullish trends on both weekly and monthly charts. This consensus among multiple technical frameworks strengthens the conviction that Dr Agarwals Eye Hospital Ltd is entering a phase of renewed strength.

On-Balance Volume and Market Cap Insights

While On-Balance Volume (OBV) data is not explicitly available for weekly and monthly periods, the price action combined with volume spikes during recent rallies suggests accumulation by institutional investors. The company holds a Market Cap Grade of 3, indicating a mid-tier market capitalisation relative to its peers in the hospital sector.

Dr Agarwals Eye Hospital Ltd’s Mojo Score stands at 65.0, reflecting a Hold rating, an upgrade from a previous Sell grade as of 29 August 2025. This improvement signals a more balanced risk-reward profile, with technical indicators now favouring cautious optimism among investors.

Comparative Performance and Sector Context

Within the hospital industry, Dr Agarwals Eye Hospital Ltd’s technical upgrades position it favourably against peers, many of which have struggled with volatility and inconsistent earnings growth. The stock’s ability to outperform the Sensex over shorter periods and maintain strong long-term returns underscores its resilience and growth potential.

However, investors should remain mindful of the stock’s 52-week high of ₹7,300.00 and low of ₹3,500.00, which highlight significant price swings. The current price near ₹5,460.00 suggests a recovery phase but also indicates that the stock has yet to reclaim its previous highs, leaving room for further upside if momentum sustains.

Investor Takeaway and Outlook

Dr Agarwals Eye Hospital Ltd’s recent technical upgrades, including bullish MACD and moving averages, suggest a positive shift in price momentum that could attract renewed investor interest. The neutral RSI readings imply that the stock is not yet overextended, providing a window for further gains without immediate risk of reversal.

Nonetheless, the mildly bearish monthly KST and the stock’s recent underperformance over the one-year period relative to the Sensex counsel prudence. Investors should monitor volume trends and broader sector developments closely, as hospital stocks remain sensitive to regulatory changes and healthcare demand dynamics.

Overall, the stock’s upgraded Mojo Grade to Hold from Sell, combined with its technical strength, positions it as a candidate for selective accumulation within a diversified portfolio. Long-term investors may find value in its strong historical returns, while traders can capitalise on the emerging bullish momentum signals.

Summary of Key Technical Indicators:

• MACD: Weekly and Monthly – Bullish


• RSI: Weekly and Monthly – Neutral (No Signal)


• Bollinger Bands: Weekly and Monthly – Bullish


• Moving Averages: Daily – Bullish


• KST: Weekly – Bullish; Monthly – Mildly Bearish


• Dow Theory: Weekly and Monthly – Mildly Bullish

Price and Return Highlights:

• Current Price: ₹5,460.00


• 52-Week High / Low: ₹7,300.00 / ₹3,500.00


• Day Change: +2.49%


• 1 Week Return: +1.21% (Sensex: +0.85%)


• 1 Month Return: -4.07% (Sensex: +0.73%)


• Year-to-Date Return: +2.36% (Sensex: +0.64%)


• 1 Year Return: -21.63% (Sensex: +7.28%)


• 3 Year Return: +349.38% (Sensex: +40.21%)


• 5 Year Return: +1,922.22% (Sensex: +79.16%)


• 10 Year Return: +2,468.20% (Sensex: +227.83%)

Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year (MRP = Rs. 34,999) Start Saving Now →